Barclays’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $128K | Sell |
53,166
-6,211
| -10% | -$13.9K | ﹤0.01% | 3922 |
|
|
2025
Q4 | $119K | Buy |
59,377
+59,376
| +5,937,600% | +$141K | ﹤0.01% | 4531 |
|
|
2025
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 5425 |
|
|
2025
Q2 | $3 | Sell |
1
-5
| -83% | -$12 | ﹤0.01% | 5178 |
|
|
2025
Q1 | $10 | Buy |
6
+5
| +500% | +$9 | ﹤0.01% | 5180 |
|
|
2024
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 5243 |
|
|
2024
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 5263 |
|
|
2024
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 4802 |
|
|
2024
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 5034 |
|
|
2023
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 5207 |
|
|
2023
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 4574 |
|
|
2023
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 4489 |
|
|
2023
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 5050 |
|
|
2022
Q4 | $3 | Hold |
1
| – | – | ﹤0.01% | 5252 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5002 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 5168 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5357 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4509 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4898 |
|
|
2021
Q2 | $0 | Sell |
1
-2,825
| -100% | -$21.3K | ﹤0.01% | 4994 |
|
|
2021
Q1 | $24K | Buy |
2,826
+2,825
| +282,500% | +$24.3K | ﹤0.01% | 4338 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5070 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5423 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 5980 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6340 |
|
|
2019
Q4 | $0 | Sell |
1
-8
| -89% | -$47 | ﹤0.01% | 6623 |
|
|
2019
Q3 | $0 | Buy |
9
+8
| +800% | +$47 | ﹤0.01% | 6960 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7108 |
|
|
2019
Q1 | $0 | Sell |
1
-480
| -100% | -$3.73K | ﹤0.01% | 7198 |
|
|
2018
Q4 | $1K | Sell |
481
-10,122
| -95% | -$38.3K | ﹤0.01% | 6812 |
|
|
2018
Q3 | $80K | Buy |
+10,603
| New | +$91.5K | ﹤0.01% | 5743 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7147 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7216 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7024 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6963 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6804 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6886 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6736 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6716 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6492 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6314 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6316 |
|
Other funds holding MBOT
VCM
CBU
AA
Barclays's MBOT Position: Q1 2026 in Review
Barclays reduced its Microbot Medical (MBOT) stake by 10% in Q1 2026, selling an estimated $13.9K and leaving 53,166 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3922.
Barclays first reported a position in MBOT in Q3 2018 and has held it in 31 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.
- Barclays held 53,166 shares of Microbot Medical worth $128K as of Q1 2026.
- Barclays sold 6,211 Microbot Medical shares in Q1 2026, an estimated $13.9K.
- Microbot Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3922 holding.
- Barclays first reported a position in Microbot Medical in Q3 2018 and has held it in 31 quarters since.
- 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.